Valeant Pharmaceuticals International, Inc. (VRX) EPS Estimated At $1.23
Jounce Therapeutics, Inc. (NASDAQ:JNCE) has 0.00% since February 23, 2017 and is. It has underperformed by 17.32% the S&P500. Valeant Pharmaceuticals Intl has a 1 year low of $8.31 and a 1 year high...